Desde hace nueve meses Finlandia tiene una vacuna anti Covid-19, pero apoyó a las grandes farmacéuticas
| dc.contributor.author | Kaila, Ilari | spa |
| dc.contributor.author | Makinen, Joona-Hermanni | spa |
| dc.date.accessioned | 2021-07-01 07:01:15 | |
| dc.date.accessioned | 2022-09-09T21:19:01Z | |
| dc.date.available | 2021-07-01 07:01:15 | |
| dc.date.available | 2022-09-09T21:19:01Z | |
| dc.date.issued | 2021-07-01 | |
| dc.description.abstract | Moderna recibió 2.500 millones de ayuda pública en Estados Unidos. Los investigadores de la Universidad de Helsinki necesitaban 50 millones para la fase III de su vacuna libre de patentes. Pero no consiguieron ayuda del Estado, pese a que gobierna un partido socialdemócrata. | spa |
| dc.description.abstract | Moderna received 2.5 billion in public support in the United States. Researchers at the University of Helsinki needed 50 million for phase III of their patent-free vaccine. But they did not get any help from the state, despite the fact that a social democratic party is in power. | eng |
| dc.format.mimetype | application/pdf | spa |
| dc.identifier.doi | 10.18601/01245996.v23n45.12 | |
| dc.identifier.eissn | 2346-2450 | |
| dc.identifier.issn | 0124-5996 | |
| dc.identifier.uri | https://bdigital.uexternado.edu.co/handle/001/12276 | |
| dc.identifier.url | https://doi.org/10.18601/01245996.v23n45.12 | |
| dc.language.iso | spa | spa |
| dc.publisher | Universidad Externado de Colombia | spa |
| dc.relation.bitstream | https://revistas.uexternado.edu.co/index.php/ecoins/article/download/7350/10072 | |
| dc.relation.citationedition | Núm. 45 , Año 2021 : Julio-diciembre | spa |
| dc.relation.citationendpage | 264 | |
| dc.relation.citationissue | 45 | spa |
| dc.relation.citationstartpage | 257 | |
| dc.relation.citationvolume | 23 | spa |
| dc.relation.ispartofjournal | Revista de Economía Institucional | spa |
| dc.rights | Ilari Kaila, Joona-Hermanni Makinen - 2021 | spa |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.coar | http://purl.org/coar/access_right/c_abf2 | spa |
| dc.rights.creativecommons | Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0. | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0 | spa |
| dc.source | https://revistas.uexternado.edu.co/index.php/ecoins/article/view/7350 | spa |
| dc.subject | Covid-19, vaccines, patents, big pharma, public funding, private profit | eng |
| dc.subject | I13, I28, I39 | eng |
| dc.subject | Covid-19, vacunas, patentes, grandes farmcéuticas, financiación pública, ganancias privadas | spa |
| dc.subject | I13, I28, I39 | spa |
| dc.subject | Covid-19, vacinas, patentes, grandes fármacos, financiamento público, lucros privados | spa |
| dc.subject | I13, I28, I39 | spa |
| dc.title | Desde hace nueve meses Finlandia tiene una vacuna anti Covid-19, pero apoyó a las grandes farmacéuticas | spa |
| dc.title.translated | Finland Had a Patent-Free COVID-19 Vaccine Nine Months Ago — But Still Went With Big Pharma | eng |
| dc.type | Artículo de revista | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
| dc.type.coar | http://purl.org/coar/resource_type/c_6501 | spa |
| dc.type.coarversion | http://purl.org/coar/version/c_970fb48d4fbd8a85 | spa |
| dc.type.content | Text | spa |
| dc.type.driver | info:eu-repo/semantics/article | spa |
| dc.type.local | Journal article | eng |
| dc.type.redcol | http://purl.org/redcol/resource_type/ARTREF | spa |
| dc.type.version | info:eu-repo/semantics/publishedVersion | spa |